MeSH D012516 - osteosarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Carboplatin | Carboplatin |  | 2005-09-21 |  |  |
| Doxorubicin | Doxorubicin |  | 1995-07-28 |  |  | |
| Doxorubicin | Myocet (previously Myocet) |  | 2000-07-13 |  |  | |
| Cisplatin | Cisplatin |  | 2000-05-16 |  |  | |
| Novast Laboratories | Carboplatin | Carboplatin |  | 2017-04-26 |  |  |
| Mylan | Carboplatin | Carboplatin |  | 2007-04-24 |  |  |
| Doxorubicin | Doxorubicin |  | 2011-10-28 |  |  | |
| Cisplatin | Cisplatin |  | 2012-04-18 |  |  | |
| Methotrexate | Methotrexate |  | 1992-05-15 |  |  | |
| NATCO Pharma | Carboplatin | Carboplatin |  | 2012-05-29 |  |  |
| Cipla | Carboplatin | Carboplatin |  | 2006-01-27 |  |  |
| Sandoz | Carboplatin | Carboplatin |  | 2005-03-18 |  |  |
| Methotrexate | Methotrexate |  | 2009-03-31 |  |  | |
| Pfizer | Doxorubicin | Adriamycin |  | 1991-01-30 |  |  |
| Doxorubicin | Doxorubicin |  | 1982-01-01 |  |  | |
| Takeda | MIFAMURTIDE | Mepact |  | 2009-03-06 |  |  |
| Dr Reddys Laboratories | Doxorubicin | Doxorubicin |  | 2017-05-15 |  |  |
| Zydus Therapeutics | Doxorubicin | Doxorubicin |  | 2020-09-10 |  |  |
| Methotrexate | Methotrexate |  | 2017-01-13 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
63%46/73
Phase 2
19%18/96
Phase 3
32%8/25
Approved: 5Overall Success rate: 4%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use